US VACCINE MAKER TARGET OF HOMOCIDE INVESTIGATION
In a criminal case guaranteed to send shockwaves throughout the international pharmaceutical industry, French authorities are targeting a US-based drug company and its executives in a homicide investigation. The multi-billion dollar corporation GlaxoSmithKline and one of its key executives are facing possible manslaughter charges stemming from allegations that the company failed to fully disclose side effects from an anti-Hepatitis "B" vaccine distributed between 1994 and 1998. Also being investigated is the French-based drug company Sanofi Pasteur, which also sold doses of the Hepatitis "B" vaccine, according to French news sources
Read article at newswithviews.com
Thursday, April 03, 2008
GlaxoSmithKline and one of its key executives are facing possible manslaughter charges re. side-effects of an anti-Hepatitis "B" vaccine
Subscribe to:
var sc_project=1725605;
var sc_invisible=0;
var sc_partition=16;
var sc_security="acf71b9a";